No abstract available
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Benzhydryl Compounds / adverse effects*
-
Benzhydryl Compounds / therapeutic use
-
Canagliflozin / adverse effects*
-
Canagliflozin / therapeutic use
-
Female
-
Glucosides / adverse effects*
-
Glucosides / therapeutic use
-
Humans
-
Janus Kinase 2 / genetics*
-
Male
-
Middle Aged
-
Polycythemia / chemically induced*
-
Polycythemia / genetics
-
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
Substances
-
Benzhydryl Compounds
-
Glucosides
-
Sodium-Glucose Transporter 2 Inhibitors
-
Canagliflozin
-
dapagliflozin
-
JAK2 protein, human
-
Janus Kinase 2
-
empagliflozin